Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients: Patient Characteristics and Type of Chemotherapy

Hsu, C. L. (2022). Prognostic Factors of Non-Small Cell Lung Cancer – Focused on Young and Old Age Patients and Circulation [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202200308
李勁毅（2022）。Clinical characteristics of resected familial lung carcinoma patients〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202200144
Surmont, V., Aerts, J. G. J. V., Tan, K. Y., Schramel, F., Vernhout, R., Hoogsteden, H. C., & Klaveren, R. J. V. (2009). Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study. Journal of Oncology, 2009(), 232-237. https://doi.org/10.1155/2009/457418
余錦秀（2016）。Survival Analysis of Stage IV Non-Small-Cell Lung Cancer of Elderly Patients〔碩士論文，義守大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0074-2806201622433800
Tomita, M., Ayabe, T., Shimizu, T., & Nakamura, A. K. (2012). Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer. Lung Cancer International, 2012(), 9-12. https://doi.org/10.1155/2012/463520